Zobrazeno 1 - 10
of 28
pro vyhledávání: '"High-Dose Chemotherapy with Stem Cell Support"'
Autor:
Nicolas André, Julien Masliah-Planchon, Cécile Faure-Conter, Rachid Abbas, Anne Geoffray, Emilie De Carli, Celine Chappe, Pierre Leblond, Anne-Isabelle Bertozzi, Gilles Palenzuela, Christine Soler, Marie-Bernadette Delisle, Fanny Fouyssac, Jacques Grill, Natacha Entz-Werle, Christelle Dufour, Claire Pluchart, Franck Bourdeaut
Publikováno v:
Neuro-Oncology
PURPOSE To assess the 3-year EFS rate of children younger than 5 years of age with high-risk medulloblastoma (MB) treated according to the prospective multicenter trial HR MB-5. PATIENTS AND METHODS After surgery, all children received 2 cycles of Et
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1edb56d4b443b91287a3e8754dad5deb
http://europepmc.org/articles/PMC7715253
http://europepmc.org/articles/PMC7715253
Autor:
Manuela Badoglio, Giovanni Rosti, Andrea Necchi, S. Lo Vullo, Patrizia Giannatempo, Paolo Pedrazzoli, Luigi Mariani, Francesco Lanza, Daniele Raggi, S. Secondino
Publikováno v:
Bone marrow transplantation. 52(8)
Administration of high-dose chemotherapy with stem cell support in patients 40 years of age or older with advanced germ cell tumours: a retrospective study from the European Society for Blood and Marrow Transplantation database
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3efd164b2400c3de60f13ae2537c186
https://pubmed.ncbi.nlm.nih.gov/28581469
https://pubmed.ncbi.nlm.nih.gov/28581469
Autor:
Michael Crump, Paul G. Richardson, Gary L. Rosner, David D. Hurd, James J. Vredenburgh, Larry Norton, Constance Cirrincione, William P. Peters, Richard L. Schilsky, Elizabeth J. Shpall, Lawrence B. Marks, Michael W. Schuster, I. C. Henderson
Publikováno v:
Journal of Clinical Oncology. 23:2191-2200
Purpose The prognosis for women with primary breast cancer involving multiple axillary nodes remains poor. High-dose chemotherapy with stem-cell support produced promising results in initial clinical trials conducted at single institutions. Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19fa080f214f170c5bb1ab3e9de604aa
https://doi.org/10.1200/jco.2005.10.202
https://doi.org/10.1200/jco.2005.10.202
Publikováno v:
Journal of Theoretical Biology. 231:69-83
Cancer patients treated with high-dose chemotherapy and autotransplanted with peripheral blood progenitor cells most often reconstitute neutrophils (0.5 x 10(9)c/l) 8-16 days after the initiation of treatment. By means of a mathematical model of huma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c31b01b40c7863cbc6828c7e1df67be
https://doi.org/10.1016/j.jtbi.2004.05.010
https://doi.org/10.1016/j.jtbi.2004.05.010
Autor:
Margarita Tokar, David B. Geffen, Itai Levi, Ofer Shpilberg, Dmitri Bobilev, Ronit Yerushalmi
Publikováno v:
Leukemia & Lymphoma. 45:1853-1856
Chemotherapy and radiotherapy have been the principal modalities of treatment for diffuse large B-cell non-Hodgkin's lymphoma (B-NHL) for over 30 years. Various treatment regimens have been designed over the years to try to increase response and cure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbb4c6af3bf81eaaeaa53bf79697c8f7
https://doi.org/10.1080/10428190410001697340
https://doi.org/10.1080/10428190410001697340
Autor:
Ragnar Winther, Ivar Østby
Publikováno v:
Journal of Mathematical Biology. 49:501-536
A class of mathematical models involving a convection-reaction partial differential equation (PDE) is introduced with reference to recovering human granulopoiesis after high dose chemotherapy with stem cell support. The stability properties of the mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f483c35445ef1d70ded936c95d1594c5
https://doi.org/10.1007/s00285-004-0274-6
https://doi.org/10.1007/s00285-004-0274-6
Autor:
Edward A. Stadtmauer
Publikováno v:
Breast Cancer Research and Treatment. 81:111-115
Seven comparative trials with over 2000 patients enrolled show no definitive evidence that high dose chemotherapy with stem cell support offers a survival advantage for metastatic breast cancer over conventional dose chemotherapy. Though numbers are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb648336b26b0bcc8002c752c3028e20
https://doi.org/10.1023/a:1026341512053
https://doi.org/10.1023/a:1026341512053
Publikováno v:
Acta Oncologica. 40:185-197
A systematic review of chemotherapy trials in several tumour types was performed by The Swedish Council of Technology Assessment in Health Care (SBU). The procedures for the evaluation of the scientiec literature are described separately (Acta Oncol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67ede82237e5f44cfe82e7a83aa6f985
https://doi.org/10.1080/02841860151116240
https://doi.org/10.1080/02841860151116240
Publikováno v:
The Indian Journal of Pediatrics. 61:469-473
The future directions of high dose chemotherapy with stem cell support will focus ultimately on improving survival.5,19 This will come about with improvements in our ability to re-infuse pristine stem cells without tumor contaminants, and to recogniz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1566692103d21c43af9e1b5950c70021
https://doi.org/10.1007/bf02751705
https://doi.org/10.1007/bf02751705